Top compounds associated with response to NHP2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.02
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.12 0.02
mRNA BRD-K01737880 CTRPv2 pan-cancer AAC 0.28 0.02
mRNA COL-3 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA nelarabine CTRPv2 pan-cancer AAC -0.091 0.02
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.12 0.02
mRNA lapatinib CTRPv2 pan-cancer AAC -0.083 0.02
mRNA Doxorubicin gCSI pan-cancer AAC 0.11 0.02
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.081 0.02
Download CSV